<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657770</url>
  </required_header>
  <id_info>
    <org_study_id>20-000994</org_study_id>
    <nct_id>NCT04657770</nct_id>
  </id_info>
  <brief_title>Telerehabilitation Early After Stroke</brief_title>
  <official_title>Telerehabilitation Early After Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Moss Rehabilitation Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to assess the feasibility of initiating telerehab in&#xD;
      early stages after stroke during patient admission to an inpatient rehabilitation facility.&#xD;
      Patients will complete 36 sessions of telerehab 6 days/week up to 8 weeks with a telehealth&#xD;
      system provided in their hospital room and at their home. The system will include&#xD;
      rehabilitation activities/exercises, education, and assessments to evaluate the patient&#xD;
      experience and measure patient outcomes at the end of a 6-week course of telerehab.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is a major cause of disability. Loss of movement is a major part of this. Studies show&#xD;
      that high doses of rehabilitation therapy can reduce disability, but many patients do not&#xD;
      receive this, e.g., due to obstacles such as difficulty accessing care. The research team has&#xD;
      previously found that telerehabilitation is an effective way to deliver care and improve&#xD;
      outcomes. These prior studies were performed after hospital discharge, when patients were&#xD;
      already back at home. The current study aims to extend this work by introducing&#xD;
      telerehabilitation to the bedside of patients admitted to an inpatient rehabilitation&#xD;
      facility. In this study, key areas of interest include issues related to, and the clinical&#xD;
      effects of, telerehabilitation that is started during the rehab admission and is continued&#xD;
      after discharge in the patient's home.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 13, 2021</start_date>
  <completion_date type="Anticipated">January 2024</completion_date>
  <primary_completion_date type="Anticipated">January 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>All enrollees will receive telerehabilitation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fugl-Meyer Arm Motor score</measure>
    <time_frame>60 days</time_frame>
    <description>measure of arm impairment, scores range from 0-66 with higher numbers reflecting less arm impairment</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Telerehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive 36 treatment sessions over 6 weeks, consisting of 3 sessions/week that are supervised rehab therapy sessions (which begin with a 30-minute videoconference with the licensed OT or PT), alternating with 3 sessions/week of unsupervised rehab therapy sessions whereby the patient follows the instructions on the screen to engage in rehab therapy. Because patients sometimes miss a session, e.g., due to a conflict, we allow up to 8 weeks for patients to complete their 36 rehab therapy sessions.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Telerehabilitation</intervention_name>
    <description>The telerehabilitation system will deliver rehabilitation treatment sessions via a secured internet-connected computer. A major component of the system is the use of games to promote therapeutically relevant movements. The subject will perform daily assigned remote-based telerehabilitation games and exercises and 5 minutes of stroke education, all guided by the telerehabilitation system. During some of the sessions, therapists will initiate a videoconference with the subject's telerehabilitation system to discuss progress, issues, and revise treatment plans as needed.</description>
    <arm_group_label>Telerehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18 years or older&#xD;
&#xD;
          2. Stroke that has been radiologically verified&#xD;
&#xD;
          3. Arm motor FM score &lt;56 (out of 66) at initial visit&#xD;
&#xD;
          4. Box &amp; Block Test score with affected arm is at least 3 blocks in 60 seconds at initial&#xD;
             visit&#xD;
&#xD;
          5. Informed consent and behavioral contract signed by the subject&#xD;
&#xD;
          6. Admitted to California Rehabilitation Institute or MossRehab for stroke rehabilitation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. A major, active, coexistent neurological or psychiatric disease (e.g., alcoholism or&#xD;
             dementia)&#xD;
&#xD;
          2. A major medical disorder that substantially reduces the likelihood that a subject will&#xD;
             be able to comply with all study procedures&#xD;
&#xD;
          3. Severe depression, as defined as Geriatric Depression Scale Score &gt;10 at initial visit&#xD;
&#xD;
          4. Significant cognitive impairment, as defined as Montreal Cognitive Assessment score&#xD;
             &lt;22 (lower score permitted if due to aphasia with approval from Dr. Cramer)&#xD;
&#xD;
          5. Deficits in communication that interfere with reasonable study participation&#xD;
&#xD;
          6. Lacking visual acuity, with or without corrective lens, of 20/40 or better in at least&#xD;
             one eye&#xD;
&#xD;
          7. Life expectancy &lt;6 months&#xD;
&#xD;
          8. Pregnant&#xD;
&#xD;
          9. Receipt of Botox to arms, legs, or trunk in the preceding 6 months, or expectation&#xD;
             that Botox will be administered to the arm, leg, or trunk within 3 months of study&#xD;
             enrollment&#xD;
&#xD;
         10. Unable to successfully perform study procedures/therapy or attend study visits, or&#xD;
             expectation of noncompliance with study procedures/therapy&#xD;
&#xD;
         11. Non-English speaking, such that subject does not speak sufficient English to comply&#xD;
             with study procedures&#xD;
&#xD;
         12. Expectation that subject will not have a single domicile address during the 6 weeks of&#xD;
             therapy that has either Verizon wireless reception or a home WiFi network and that has&#xD;
             space for the telerehab system&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Steve Cramer, MD</last_name>
    <phone>424-522-7874</phone>
    <email>sccramer@mednet.ucla.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>California Rehabilitation Institute</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90067</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steven Cramer, MD</last_name>
      <phone>424-522-7874</phone>
      <email>sccramer@mednet.ucla.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tiffany Nguyen, MOT</last_name>
      <phone>424-522-7874</phone>
      <email>Tiffanguyen@CaliforniaRehabInstitute.com</email>
    </contact_backup>
    <investigator>
      <last_name>Steven Cramer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Moss Rehabilitation Research Institute</name>
      <address>
        <city>Elkins Park</city>
        <state>Pennsylvania</state>
        <zip>19027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dylan Edwards, PhD</last_name>
      <phone>215-663-6411</phone>
      <email>EdwardDy@einstein.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sapna Kumar, MS</last_name>
      <phone>215-663-6227</phone>
      <email>KumarSap@einstein.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Dylan Edwards, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alberto Esquenazi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>December 1, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>September 27, 2021</last_update_submitted>
  <last_update_submitted_qc>September 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>Steven C. Cramer, MD, FAAN, FAHA</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>telerehab</keyword>
  <keyword>telerehabilitation</keyword>
  <keyword>telehealth</keyword>
  <keyword>brain plasticity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>A deidentified dataset will be shared with appropriate personnel after the main study manuscript is published.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Likely starting 1-2 years after study completion, lasting for several years thereafter.</ipd_time_frame>
    <ipd_access_criteria>Data will be shared using common data formats with appropriate personnel.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 21, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT04657770/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

